Mitoxantrone Terminated Phase 2 Trials for Relapsed Cutaneous T Cell Lymphom Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02597153Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas